Journal article

Focus on molecules: cytochrome P450 family 4, subfamily V, polypeptide 2 (CYP4V2).

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Mackay, D., & Halford, S. (2012). Focus on molecules: cytochrome P450 family 4, subfamily V, polypeptide 2 (CYP4V2). Experimental Eye Research, 102, 111–112.

MLA Style

Mackay, D, and S Halford. “Focus on Molecules: Cytochrome P450 Family 4, Subfamily V, Polypeptide 2 (CYP4V2).” Experimental Eye Research, vol. 102, 2012, pp. 111–12.

Chicago Style

Mackay, D, and S Halford. 2012. “Focus on Molecules: Cytochrome P450 Family 4, Subfamily V, Polypeptide 2 (CYP4V2).” Experimental Eye Research 102: 111–12.
Print

Access Document

Publisher copy:: 10.1016/j.exer.2011.06.019

Authors

+ Mackay, D More by this author

Role:: Author

+ Halford, S More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Clinical Neurosciences
Role:: Author

Journal:: Experimental eye research More from this journal
Volume:: 102
Pages:: 111-112
Publication date:: 2012-09-01
DOI:: 10.1016/j.exer.2011.06.019
EISSN:: 1096-0007
ISSN:: 0014-4835

Language:: English
Keywords:: Retinal Dystrophies

Corneal Dystrophies, Hereditary

Retinal Diseases

Lipid Metabolism

Humans

Molecular Structure

Cytochrome P-450 Enzyme System
Pubs id:: pubs:251621
UUID:: uuid:0f2c958b-442f-490a-bae3-6ed06fe24bbb
Local pid:: pubs:251621
Source identifiers:: 251621
Deposit date:: 2012-12-19
ARK identifier:: ark:/29072/ora_0f2c958b442f490abae36ed06fe24bbb

Terms of use

Copyright date:: 2012

Licence:: Terms and Conditions of Use for Oxford University Research Archive

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP